GS-9620, an Oral Agonist of Toll-Like Receptor-7, Induces Prolonged Suppression of Hepatitis B Virus in Chronically Infected Chimpanzees-Reference-Cited by-同舟云学术

GS-9620, an Oral Agonist of Toll-Like Receptor-7, Induces Prolonged Suppression of Hepatitis B Virus in Chronically Infected Chimpanzees

Published:2013-06 Issue:7 Volume:144 Page:1508-1517.e10
ISSN:0016-5085
Container-title:Gastroenterology
language:en
Short-container-title:Gastroenterology

Author:

Lanford Robert E.,Guerra Bernadette,Chavez Deborah,Giavedoni Luis,Hodara Vida L.,Brasky Kathleen M.,Fosdick Abigail,Frey Christian R.,Zheng Jim,Wolfgang Grushenka,Halcomb Randall L.,Tumas Daniel B.

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference36 articles.

1. Hepatitis B therapy;Kwon;Nat Rev Gastroenterol Hepatol,2011

2. Chronic hepatitis B: peginterferon or nucleos(t)ide analogues?;Sonneveld;Liver Int,2011

3. Molecular genetics of HBV infection;Locarnini;Antivir Ther,2010

4. High rates of HBsAg seroconversion in HBeAg-positive chronic hepatitis B patients responding to interferon: a long-term follow-up study;Moucari;J Hepatol,2009

5. Sustained response of hepatitis B e antigen-negative patients 3 years after treatment with peginterferon alpha-2a;Marcellin;Gastroenterology,2009

Cited by 330 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Using exploratory pharmacokinetic and pharmacodynamic analyses to predict the probability of flu‐like symptoms in healthy volunteers and patients with chronic hepatitis B treated with the toll‐like receptor 7 agonist ruzotolimod;Clinical and Translational Science;2024-08

2. The immune response in chronic HBV infection;Journal of Viral Hepatitis;2024-06-06

3. Meeting the Challenge of Controlling Viral Immunopathology;International Journal of Molecular Sciences;2024-04-01

4. The combination of Schisandrin C and Luteolin synergistically attenuates hepatitis B virus infection via repressing HBV replication and promoting cGAS-STING pathway activation in macrophages;Chinese Medicine;2024-03-18

5. Recent advances in different interactions between toll-like receptors and hepatitis B infection: a review;Frontiers in Immunology;2024-03-13